Concepedia

Rumeng Pan

RP

Statistics

Publications

5

Citations

121

H-Index

5

Active since

2023

Affiliations

First Affiliated Hospital of Xi'an Jiaotong University(Current)

Zunyi Medical University

Rumeng Pan is an author at First Affiliated Hospital of Xi'an Jiaotong University specializing in adverse drug events, adverse drug event reporting, and adverse reactions reporting.

Publications per year

2023–2024

5

Publications

5

A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say?

Zhiwei Cui, Feiyan Cheng, Lihui Wang et al. · Frontiers in Pharmacology · 2023 · 49 citations · Full text

, , +16

Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy

Zhiwei Cui, Fan Zou, Rongli Wang et al. · World Journal of Surgical Oncology · 2023 · 29 citations · Full text

, , +17

Endometrial stem cells alleviate cisplatin-induced ferroptosis of granulosa cells by regulating Nrf2 expression

Rumeng Pan, Rongli Wang, Feiyan Cheng et al. · Reproductive Biology and Endocrinology · 2024 · 23 citations · Full text

, , +14

From genomic spectrum of NTRK genes to adverse effects of its inhibitors, a comprehensive genome-based and real-world pharmacovigilance analysis

Zhiwei Cui, Zhen Zhai, De Xie et al. · Frontiers in Pharmacology · 2024 · 10 citations · Full text

, , +17

FGF2 promotes the proliferation of injured granulosa cells in premature ovarian failure via Hippo-YAP signaling pathway

Feiyan Cheng, Jingyuan Wang, Rongli Wang et al. · Molecular and Cellular Endocrinology · 2024 · 10 citations

, , +14

1–5 of 5